Some breast cancer patients could avoid chemotherapy treatment without jeopardizing their chances of survival by taking a genetic test to determine the risk of their cancer recurring, a study has found. Serene Branson reports.
Choosing to Wait: A New Approach to Treating Breast Cancer at it’s Earliest Stages. Colletti, 60, was diagnosed with ductal carcinoma in situ (DCIS), also known as Stage 0 breast cancer, in April 2014. But [More]